News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
857,657 Results
Type
Article (87204)
Company Profile (705)
Press Release (769724)
Multimedia
Podcasts (163)
Webinars (24)
Section
Business (232961)
Career Advice (4136)
Deals (39781)
Drug Delivery (133)
Drug Development (91194)
Employer Resources (200)
FDA (18244)
Job Trends (17385)
News (397170)
Policy (39890)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (33)
Allergies (117)
Alliances (56979)
ALS (135)
Alzheimer's disease (1638)
Antibody-drug conjugate (ADC) (204)
Approvals (18230)
Artificial intelligence (451)
Autoimmune disease (43)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (145)
Biotechnology (483)
Bladder cancer (117)
Brain cancer (46)
Breast cancer (433)
Cancer (3492)
Cardiovascular disease (304)
Career advice (3550)
Career pathing (36)
CAR-T (225)
CDC (45)
Cell therapy (621)
Cervical cancer (29)
Clinical research (74861)
Collaboration (1263)
Company closure (4)
Compensation (845)
Complete response letters (50)
COVID-19 (2939)
CRISPR (77)
C-suite (486)
Cystic fibrosis (128)
Data (3671)
Decentralized trials (2)
Denatured (58)
Depression (93)
Diabetes (409)
Diagnostics (7037)
Digital health (29)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (213)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (180)
Earnings (98622)
Editorial (52)
Employer branding (25)
Employer resources (169)
Events (132342)
Executive appointments (951)
FDA (20440)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1119)
Gene editing (163)
Generative AI (44)
Gene therapy (489)
GLP-1 (984)
Government (5342)
Grass and pollen (7)
Guidances (332)
Healthcare (20934)
HIV (48)
Huntington's disease (33)
IgA nephropathy (52)
Immunology and inflammation (211)
Immuno-oncology (17)
Indications (45)
Infectious disease (3154)
Inflammatory bowel disease (177)
Inflation Reduction Act (13)
Influenza (86)
Intellectual property (158)
Interviews (814)
IPO (17920)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (67)
Layoffs (619)
Leadership (30)
Legal (10143)
Liver cancer (89)
Longevity (12)
Lung cancer (505)
Lymphoma (250)
Machine learning (22)
Management (65)
Manufacturing (550)
MASH (115)
Medical device (14817)
Medtech (14834)
Mergers & acquisitions (22669)
Metabolic disorders (1053)
Multiple sclerosis (115)
NASH (23)
Neurodegenerative disease (178)
Neuropsychiatric disorders (49)
Neuroscience (2516)
NextGen: Class of 2025 (7687)
Non-profit (5094)
Now hiring (54)
Obesity (532)
Opinion (302)
Ovarian cancer (112)
Pain (150)
Pancreatic cancer (142)
Parkinson's disease (213)
Partnered (27)
Patents (378)
Patient recruitment (253)
Peanut (56)
People (66025)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23079)
Phase II (32503)
Phase III (24472)
Pipeline (2413)
Policy (277)
Postmarket research (3554)
Preclinical (10420)
Press Release (72)
Prostate cancer (170)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (590)
Real estate (7409)
Recruiting (76)
Regulatory (27635)
Reports (64)
Research institute (2673)
Resumes & cover letters (650)
Rett syndrome (11)
RNA editing (15)
RSV (63)
Schizophrenia (116)
Series A (183)
Series B (138)
Service/supplier (30)
Sickle cell disease (75)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (39)
Startups (4314)
State (2)
Stomach cancer (17)
Supply chain (91)
Tariffs (81)
The Weekly (103)
Vaccines (1003)
Venture capital (63)
Weight loss (364)
Women's health (56)
Worklife (21)
Date
Today (119)
Last 7 days (683)
Last 30 days (2648)
Last 365 days (34158)
2025 (23196)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (78)
Alaska (7)
Arizona (292)
Arkansas (14)
Asia (50771)
Australia (8916)
California (8812)
Canada (2677)
China (824)
Colorado (373)
Connecticut (391)
Delaware (237)
Europe (116587)
Florida (1303)
Georgia (302)
Hawaii (3)
Idaho (67)
Illinois (783)
India (45)
Indiana (425)
Iowa (19)
Japan (265)
Kansas (121)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1206)
Massachusetts (6657)
Michigan (294)
Minnesota (540)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (99)
New Hampshire (75)
New Jersey (2431)
New Mexico (31)
New York (2405)
North Carolina (1344)
North Dakota (10)
Northern California (3920)
Ohio (279)
Oklahoma (18)
Oregon (49)
Pennsylvania (1847)
Puerto Rico (18)
Rhode Island (44)
South America (1654)
South Carolina (45)
South Dakota (1)
Southern California (3332)
Tennessee (142)
Texas (1373)
United States (32760)
Utah (264)
Virginia (237)
Washington D.C. (82)
Washington State (756)
West Virginia (4)
Wisconsin (91)
There are 857,657 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation
September 10, 2025
·
9 min read
Podcast
Unpacking the Latest MAHA Report, RFK’s Senate Appearance, FDA’s CRL Drop and More
This week’s release of the Make America Health Again report TKTK; Health Secretary Robert F. Kennedy Jr.’s faceoff with senators last week amounted to political theater; the FDA promises complete response letters in real time and shares details on a new rare disease framework; and Summit disappoints at the World Conference on Lung Cancer in Barcelona.
September 10, 2025
·
1 min read
·
Jef Akst
Press Releases
Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update
September 10, 2025
·
4 min read
Press Releases
Cumulus Neuroscience Appoints Robert Ballantine to Board of Directors
September 10, 2025
·
3 min read
Job Trends
California’s $23.9M in Life Sciences Grants Could Add 10,000 Jobs in LA Area
Four Los Angeles County life sciences projects are receiving funding to support goals that include adding jobs, creating multitenant facilities for graduation-stage companies, financially supporting emerging businesses and attracting large employers to the area.
September 10, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Novo Nordisk to streamline operations and reinvest for growth
September 10, 2025
·
4 min read
Press Releases
ImmVira Announces First-in-Human Data of Engineered Exosome MVR-EX105 for Fat Reduction and Muscle Preservation by Topical Application at 2025 Annual Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders
September 10, 2025
·
5 min read
Press Releases
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
September 10, 2025
·
6 min read
Press Releases
Bioversys Reports Corporate Highlights and Key Financials For the First Half 2025
September 10, 2025
·
10 min read
Press Releases
Alnylam Announces Pricing of Upsized Offering of $575 Million Convertible Senior Notes
September 10, 2025
·
11 min read
1 of 85,766
Next
